Evidence map›Paper›PMID 30525563›Full record

ArticleJournal of the American Chemical Society2018

Total Enzyme Syntheses of Napyradiomycins A1 and B1.

Shaun M K McKinnie, Zachary D Miles, Peter A Jordan, Takayoshi Awakawa, Henry P Pepper, Lauren A M Murray, Jonathan H George, Bradley S Moore

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. In Silico Screening ofBiologics : targets & therapy · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Ru(phen)ChemistryOpen · 2023
    Article
  15. Naturally Occurring Organohalogen Compounds-A Comprehensive Review.Progress in the chemistry of organic natural products · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shaun M K McKinnieCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego , La Jolla , California 92093 , United States.ORCID 0000-0001-6776-6455
Zachary D MilesCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego , La Jolla , California 92093 , United States.
Peter A JordanCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego , La Jolla , California 92093 , United States.
Takayoshi AwakawaCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego , La Jolla , California 92093 , United States.
Henry P PepperDepartment of Chemistry , University of Adelaide , Adelaide , South Australia 5005 , Australia.
Lauren A M MurrayDepartment of Chemistry , University of Adelaide , Adelaide , South Australia 5005 , Australia.
Jonathan H GeorgeDepartment of Chemistry , University of Adelaide , Adelaide , South Australia 5005 , Australia.ORCID 0000-0002-7330-2160
Bradley S MooreCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego , La Jolla , California 92093 , United States.ORCID 0000-0002-4652-1253

Funding

ENGINEERING DIVERSITY WITH ENTEROCIN BIOSYNTHESIS GENER01AI047818 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MOORE, BRADLEY S · 2000 to 2022
$5.2M
NIAID NIH HHS R01 AI047818
6 · The paper itself

Abstract

The biosynthetic route to the napyradiomycin family of bacterial meroterpenoids has been fully described 32 years following their original isolation and 11 years after their gene cluster discovery. The antimicrobial and cytotoxic natural products napyradiomycins A1 and B1 are produced using three organic substrates (1,3,6,8-tetrahydroxynaphthalene, dimethylallyl pyrophosphate, and geranyl pyrophosphate), and catalysis via five enzymes: two aromatic prenyltransferases (NapT8 and T9); and three vanadium dependent haloperoxidase (VHPO) homologues (NapH1, H3, and H4). Building upon the previous characterization of NapH1, H3, and T8, we herein describe the initial (NapT9, H1) and final (NapH4) steps required for napyradiomycin construction. This remarkably streamlined biosynthesis highlights the utility of VHPO enzymology in complex natural product generation, as NapH4 efficiently performs a unique chloronium-induced terpenoid cyclization to establish two stereocenters and a new carbon-carbon bond, and dual-acting NapH1 catalyzes chlorination and etherification reactions at two distinct stages of the pathway. Moreover, we employed recombinant napyradiomycin biosynthetic enzymes to chemoenzymatically synthesize milligram quantities in one pot in 1 day. This method represents a viable enantioselective approach to produce complex halogenated metabolites, like napyradiomycin B1, that have yet to be chemically synthesized.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBiocatalysisDimethylallyltranstransferaseNaphthoquinonesPeroxidasesStreptomycesAnti-Bacterial AgentsBacterial ProteinsDimethylallyltranstransferaseNaphthoquinonesnapyradiomycin A1napyradiomycin B1Peroxidases

Identifiers

PMID30525563
PMCPMC6491662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.